V019-7589 Screening compound: 3-fluoro-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-N-[2-(morpholin-4-yl)ethyl]benzamide

V019-7589 Screening compound: 3-fluoro-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-N-[2-(morpholin-4-yl)ethyl]benzamide
V019-7589 Screening compound: 3-fluoro-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-N-[2-(morpholin-4-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-7589
3-fluoro-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-N-[2-(morpholin-4-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-7589

Molecular Formula

C28H35FN4O6S (C28 H35 FN4 O6 S)

Compound Name

3-fluoro-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-N-[2-(morpholin-4-yl)ethyl]benzamide

IUPAC name

3-fluoro-N-{[1-(2-methoxyethyl)-2-[(3-methoxyphenyl)methanesulfonyl]-1H-imidazol-5-yl]methyl}-N-[2-(morpholin-4-yl)ethyl]benzamide

SMILES

COCCn1c(S(Cc2cc(OC)ccc2)(=O)=O)ncc1CN(CCN1CCOCC1)C(c1cc(F)ccc1)=O

InChI

InChI=1S/C28H35FN4O6S/c1-37-14-13-33-25(19-30-28(33)40(35,36)21-22-5-3-8-26(17-22)38-2)20-32(10-9-31-11-15-39-16-12-31)27(34)23-6-4-7-24(29)18-23/h3-8,17-19H,9-16,20-21H2,1-2H3

InChI Key

KTQSWXLACZZFHN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19824184

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

574.67

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

14.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.063

Distribution Coefficient, logD

2.057

Water Solubility, LogSw

-2.43

Polar Surface Area

84.597

Acid Dissociation Constant (pKa)

20.02

Base Dissociation Constant (pKb)

5.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

V019-7589 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V019-7589 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-7589?
Check Price and Availability of V019-7589, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-7589 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-7589
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-7589
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-7589 available by request